Back to Results
First PageMeta Content
Genomics / Pharmacology / Amines / Quinazolines / Evidence-based medicine / Personalized medicine / Proteomics / Biomarker / Erlotinib / Medicine / Biology / Chemistry


A series of partnering trend analyses and of business profiles from leading biotech and pharmaceutical companies looking to develop relationships with prospective partners September[removed]Diseases related to the immune s
Add to Reading List

Document Date: 2014-08-27 15:38:06


Open Document

File Size: 1,57 MB

Share Result on Facebook

City

Chicago / /

Company

Biodesix / ADVERTISEMENT FEATURE Biodesix Inc. / CONTACT DETAILS Biodesix Inc. / /

/

Event

FDA Phase / /

IndustryTerm

routine tool / technology leads / pharmaceutical / broader applications / advertising feature / diagnostic tools / treatment of their disease / analytical algorithms / treatment of their patient’s disease / lung cancer therapies / chemicals / /

MedicalCondition

HIV / colorectal cancer / certain diseases / rheumatoid arthritis / patient’s disease / small cell lung cancer / MS / head cancers / breast cancer / cancers / squamous cell lung cancer / cancer / disease / NSCLC / lung cancer / Diseases / neck cancers / /

MedicalTreatment

lung cancer therapies / chemotherapy / drug therapies / /

Organization

American Society of Clinical Oncology / Medicare / /

Person

David Brunel / Paul Beresford / Francis Collins / Heinrich Röder / /

/

Position

driver / vice president of business development and strategic marketing / technician / Chief Technology Officer / CEO / director of the National Institutes of Health / leader / /

Product

Humira / Tarceva / VeriStrat® / /

ProvinceOrState

Mississippi / /

PublishedMedium

Nature Biotechnology / /

Technology

genomics / proteomics / diagnostic tests / Biotechnology / MALDI technology / human genome / laser / Drug Discovery / genetic code / chemotherapy / genotype / using both genomics / /

URL

www.biodesix.c / /

SocialTag